Search clinical trials for: ZD6474 (vandetanib) 100mg
Total 2535 results
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompletedUnresectable Locally Advanced or Metastatic, Medullary Thyroid CarcinomaJapan
-
Phloronol Inc.Worldwide Clinical TrialsCompleted
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.CompletedDiabetic Neuropathy PeripheralChina
-
Inmagene LLCCompleted
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
Genzyme, a Sanofi CompanyCompletedCarcinoma | Lung Cancer | Non-Small Cell Lung
-
National Cancer Institute (NCI)CompletedRenal Cancer | Von Hippel LindauUnited States
-
Bacainn Therapeutics, Inc.CompletedHealthy VolunteersUnited States
-
M.D. Anderson Cancer CenterUnited States Department of Defense; AstraZenecaCompleted
-
St. Jude Children's Research HospitalCompletedBrain and Central Nervous System TumorsUnited States
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)Not yet recruitingPregnancy | HIV | PreventionMalawi, Zimbabwe
-
Genzyme, a Sanofi CompanyCompletedThyroid CancerUnited States, France
-
Genzyme, a Sanofi CompanyActive, not recruitingTo Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid CancerThyroid CancerUnited States, Italy, Poland, Russian Federation, United Kingdom, Netherlands, Israel, Czechia, India
-
Ensol BioscienceCompleted
-
Genzyme, a Sanofi CompanyCompletedThyroid CancerItaly, Spain, Romania, Netherlands, Canada, United States, Switzerland, Australia
-
Genzyme, a Sanofi CompanyWorldwide Clinical TrialsCompletedSymptomatic, Aggressive, Sporadic, Unresectable, Locally | Advanced/Metastatic Medullary Thyroid Cancer (MTC)Belgium, Italy, Netherlands, Spain, France, Germany, United Kingdom, Luxembourg
-
University of ChicagoNational Cancer Institute (NCI)CompletedPrecancerous Condition | Lip and Oral Cavity Squamous Cell Carcinoma | Oral Cavity Verrucous CarcinomaUnited States
-
Dong Wha Pharmaceutical Co. Ltd.CompletedDiabetic NephropathyKorea, Republic of
-
SanofiTerminatedNon-small Cell Lung Cancer (NSCLC)Netherlands
-
Genzyme, a Sanofi CompanyActive, not recruitingThyroid CancerUnited States, Australia, Austria, Belgium, Brazil, Canada, Czechia, Denmark, France, Germany, Hungary, India, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Romania, Russian Federation, Serbia, Spain, Sweden, Switz...
-
Medicines for Malaria VentureCompletedHealthy Volunteers | Malaria Falciparum | Malaria VivaxUnited States
-
Genzyme, a Sanofi CompanyCompletedCarcinoma, HepatocellularTaiwan
-
National Cancer Institute (NCI)Terminated
-
Genzyme, a Sanofi CompanyCompletedColorectal CancerGermany
-
University of Colorado, DenverAstraZenecaCompleted
-
MyMD Pharmaceuticals, Inc.CompletedFrailty | Sarcopenia | AgingUnited States
-
M.D. Anderson Cancer CenterAstraZenecaTerminatedNon-Small Cell Lung CancerUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingAtopic DermatitisChina
-
Vigonvita Life SciencesCompletedHealthy SubjectsChina
-
National Cancer Institute (NCI)TerminatedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsUnited States
-
National Cancer Institute (NCI)CompletedGlioblastoma Multiforme | Gliosarcoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | Anaplastic Mixed OligoastrocytomaUnited States
-
Ronald WeigelAstraZenecaTerminatedInvasive Breast CancerUnited States
-
Shanghai Jiatan Pharmatech Co., LtdCompleted
-
Genzyme, a Sanofi CompanyCompletedAdenocarcinoma | Metastatic | ColorectalUnited Kingdom, Belgium
-
Bio-Thera SolutionsCompletedNon-Hodgkin's LymphomaChina
-
Chengdu Zenitar Biomedical Technology Co., LtdRecruitingRheumatoid Arthritis (RA) | Inflammatory Bowel Disease - IBD1China
-
Curon Biopharmaceutical (Australia) Co Pty LtdNovotech (Australia) Pty LimitedTerminatedRelapsed Lymphoid Malignancies | Refractory Lymphoid MalignanciesAustralia
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownAcute Myeloid LeukemiaChina
-
Chengdu Zenitar Biomedical Technology Co., LtdRecruiting
-
Genzyme, a Sanofi CompanyTerminated
-
OSE ImmunotherapeuticsRecruitingDose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or LymphomasLymphoma | Solid Advanced TumorFrance, Belgium
-
NeuroBo Pharmaceuticals Inc.Dong-A ST Co., Ltd.Completed
-
Dong-A ST Co., Ltd.Completed
-
Chengdu Zenitar Biomedical Technology Co., LtdRecruiting
-
Shanghai Vinnerna Biosciences Co., Ltd.Withdrawn
-
Genzyme, a Sanofi CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States, France, Italy, Korea, Republic of, Peru, Spain, United Kingdom, Philippines, China, Germany, Hong Kong, Argentina, Austria, Canada, Israel, Taiwan, Mexico, Thailand, Belgium, Australia, Singapore, Netherlands
-
SanofiCompleted
-
Jill M KolesarNational Cancer Institute (NCI); NovartisRecruitingMetastatic Melanoma | BRAF Gene MutationUnited States